Karriereverlauf von Carl Damiani
Ehemalige bekannte Positionen von Carl Damiani
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRANSITION THERAPEUTICS INC | Geschäftsführer | 11.07.2014 | 01.12.2016 |
| Corporate Officer/Principal | 01.10.2003 | 11.07.2014 | |
| Präsident | 16.06.2015 | 01.12.2016 |
Statistik
International
| Kanada | 2 |
Operativ
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
| President | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
- Börse
- Insiders
- Carl Damiani
- Erfahrung
